the primary federal law governing the manufacture , distribution , and use of prescription and illicit opioids is the controlled substances act ( csa or the act ) , which is administered and enforced by the drug enforcement administration ( dea ) in the u.s. department of justice .
t he alarming rise in drug overdose deaths involving opioids over the past two decades has prompted the federal government to examine the causes of the public health crisis , identify possible solutions to counteract the problem , and take actions to address the crisis .
the csa provides the legal regime through which the federal government ( 1 ) regulates and facilitates the lawful production , possession , and distribution of controlled substances , including opioids ; ( 2 ) prevents diversion of these substances from legitimate purposes ; and ( 3 ) penalizes unauthorized activities involving controlled substances .
4095 ) would repeal the ensuring patient access and effective drug enforcement act of 2016 ( epaedea ) ( p.l .
legislative proposals introduced in the 115 th congress include the following: changes to the dea's authority to deny , revoke , or suspend a registration , and to issue immediate suspension order s .
115-271 ) ( the support for patients and communities act , or the support act ) that president trump signed into law on october 24 , 2018 .
after that , the report examines dea actions taken that are specifically targeted at addressing opioid abuse and describes recently enacted laws amending the csa that impact the opioid regulatory system , including the substance use - disorder prevention that promotes opioid recovery and treatment for patients and communities act ( p.l .
the regulatory framework under the csa relies primarily on a registration system: the act requires persons who handle controlled substances ( such as drug manufacturers , wholesale distributors , exporters , importers , health care professionals , hospitals , pharmacies , and scientific researchers ) to register with the dea and comply with the terms and conditions of the registration .
the dea opioid enforcement restoration act of 2017 ( h.r .
these potential additional amendments to the csa may resemble opioid legislation introduced , but not enacted to date , in the 115 th congress .
in recent years , congress has also taken action to address perceived deficiencies in the federal regulatory regime governing opioids .
such violations may include ( 1 ) "regulatory" offenses committed by registrants who do not adhere to their responsibilities under the csa , thereby increasing the risk of diversion , and ( 2 ) illicit trafficking or possession crimes that occur outside the "closed system" of authorized controlled substance distribution that primarily involve nonregistrants .
the csa provides civil and criminal penalties for any unlawful manufacture , distribution , importation , exportation , or possession of controlled substances .
the opioid preventing abuse through continuing education ( pace ) act of 2017 ( h.r .
to date , the most comprehensive legislative response to the overprescribing and abuse of opioids is the substance use â€“ disorder prevention that promotes opioid recovery and treatment for patients and communities act ( p.l .
the 116 th congress may consider legislation to amend the csa beyond the changes made by the support act .